Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

CD19 CAR-T & Follicular lymphoma (FL)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

CD19 CAR-T is an established option for relapsed/refractory Follicular lymphoma (FL), especially after at least 2 prior systemic lines, with high response rates and a meaningful proportion of durable complete remissions in pivotal studies and reviews.
Jacobs & Jacobson 2024 Front Oncol 14: 1384600
Testa et al. 2024 Mediterr J Hematol Infect Dis 16(1): e2024012

…

References (Sources)

CAR-T Cell Therapy for Follicular Lymphomas
Testa et al. 2024 Mediterr J Hematol Infect Dis 16(1): e2024012
Review
The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
Jacobs & Jacobson 2024 Front Oncol 14: 1384600
Review

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!

CD19 CAR-T & Follicular lymphoma (FL)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat